CHOLINESTERASE INHIBITOR EFFECTS ON EXTRACELLULAR ACETYLCHOLINE IN RAT CORTEX

被引:46
作者
MESSAMORE, E [1 ]
WARPMAN, U [1 ]
OGANE, N [1 ]
GIACOBINI, E [1 ]
机构
[1] SO ILLINOIS UNIV,SCH MED,DEPT PHARMACOL,POB 19230,SPRINGFIELD,IL 62794
关键词
ACETYLCHOLINE; MICRODIALYSIS; ACETYLCHOLINESTERASE; PHYSOSTIGMINE; HEPTYLPHYSOSTIGMINE; TETRAHYDROAMINOACRIDINE; TACRINE;
D O I
10.1016/0028-3908(93)90182-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A microdialysis technique was used to sample acetylcholine (ACh) from the cerebral cortex of conscious rats. We thus investigated the effects of systemically administered cholinesterase inhibitors (ChEI) such as physostigmine (300 mug/kg), heptylphysostigmine (5 mg/kg) and tetrahydroaminoacridine (tacrine, 5 mg/kg) on extracellular ACh levels. Baseline quantities of extracellular ACh could be detected, even in the absence of ChEI. Acetylcholine levels increased to 1100% over baseline within 30 min of physostigmine administration and returned to control levels after 1.25 hr. Heptylphysostigmine elicited a maximal increase of 1000% within 1.5 hr, and the effect persisted up to 9.5 hr. A 500% increase was observed 1.5 hr after tacrine administration, and ACh returned to control levels after 4 hr. Although the ACh effects observed in this study correlated with previously determined levels of acetylcholinesterase (AChE) inhibition, we conclude that measures of cortical AChE activity alone are not sufficient to predict extracellular ACh levels following systemic ChEI administration.
引用
收藏
页码:745 / 750
页数:6
相关论文
共 26 条
  • [1] MECHANISMS OF CHOLINESTERASE INHIBITION IN SENILE DEMENTIA OF THE ALZHEIMER TYPE - CLINICAL, PHARMACOLOGICAL, AND THERAPEUTIC ASPECTS
    BECKER, RE
    GIACOBINI, E
    [J]. DRUG DEVELOPMENT RESEARCH, 1988, 12 (3-4) : 163 - 195
  • [2] BECKER RE, 1991, CHOLINERGIC BASIS AL, P263
  • [3] A LONG-LASTING CHOLINESTERASE INHIBITOR AFFECTING NEURAL AND BEHAVIORAL PROCESSES
    BRUFANI, M
    CASTELLANO, C
    MARTA, M
    OLIVERIO, A
    PAGELLA, PG
    PAVONE, F
    POMPONI, M
    RUGARLI, PL
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 26 (03) : 625 - 629
  • [4] ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION
    COYLE, JT
    PRICE, DL
    DELONG, MR
    [J]. SCIENCE, 1983, 219 (4589) : 1184 - 1190
  • [5] A SIMPLE, SENSITIVE, AND ECONOMIC ASSAY FOR CHOLINE AND ACETYLCHOLINE USING HPLC, AND ENZYME REACTOR, AND AN ELECTROCHEMICAL DETECTOR
    DAMSMA, G
    WESTERINK, BHC
    HORN, AS
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) : 1649 - 1652
  • [6] BASAL ACETYLCHOLINE-RELEASE IN FREELY MOVING RATS DETECTED BY ONLINE TRANS-STRIATAL DIALYSIS - PHARMACOLOGICAL ASPECTS
    DAMSMA, G
    WESTERINK, BHC
    DEBOER, P
    DEVRIES, JB
    HORN, AS
    [J]. LIFE SCIENCES, 1988, 43 (14) : 1161 - 1168
  • [7] THE EFFECT OF ACETYLCHOLINESTERASE INHIBITION ON THE RELEASE OF ACETYLCHOLINE FROM THE STRIATUM INVIVO - INTERACTION WITH AUTORECEPTOR RESPONSES
    DEBOER, P
    WESTERINK, BHC
    HORN, AS
    [J]. NEUROSCIENCE LETTERS, 1990, 116 (03) : 357 - 360
  • [8] THE EFFECT OF HEPTYL-PHYSOSTIGMINE, A NEW CHOLINESTERASE INHIBITOR, ON THE CENTRAL CHOLINERGIC SYSTEM OF THE RAT
    DESARNO, P
    POMPONI, M
    GIACOBINI, E
    TANG, XC
    WILLIAMS, E
    [J]. NEUROCHEMICAL RESEARCH, 1989, 14 (10) : 971 - 977
  • [9] A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE
    FARLOW, M
    GRACON, SI
    HERSHEY, LA
    LEWIS, KW
    SADOWSKY, CH
    DOLANURENO, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18): : 2523 - 2529
  • [10] PHYSOSTIGMINE, TACRINE AND METRIFONATE - THE EFFECT OF MULTIPLE DOSES ON ACETYLCHOLINE METABOLISM IN RAT-BRAIN
    HALLAK, M
    GIACOBINI, E
    [J]. NEUROPHARMACOLOGY, 1989, 28 (03) : 199 - 206